Intelligence · INN directory
Pharmaceutical Drugs
Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.
Quick answer
NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.
Recently updated
FDA-approved
-
collodion flexible
NULL
-
coronavirus (sars-cov-2) rna vaccine
DAICHIRONA PARTIAL CHANGE APPROVAL
-
coronavirus (sars-cov-2) rna vaccine (active ingredient: mafb-7256a)
DAICHIRONA (MONOVALENT, OMICRON XBB.1.5) PARTIAL CHANGE APPROVAL
-
coronavirus (sars-cov-2) rna vaccine (active ingredient: ufrenmeran)
DAICHIRONA (MONOVALENT, ORIGINAL) INITIAL APPROVAL
-
coronavirus (sars-cov-2) rna vaccine (active ingredients of bivalent original/omicron ba.1 vaccine: elasomeran and imelasomeran) (active ingredients of bivalent original/omicron ba.4-5 vaccine: elasomeran and davesomeran) (active ingredient of monovalent
SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) (BIVALENT, ORIGINAL/OMICRON BA.4-5) (MONOVALENT, OMICRON XBB.1.5) PARTIAL CHANGE APPROVAL
-
coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran)
SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL
-
coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)
COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL
-
coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran)
SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL
-
coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: tozinameran)
COMIRNATY (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL
-
coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)
SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL
-
coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and famtozinameran)
COMIRNATY FOR 5 TO 11 YEARS OLD (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL
-
coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran)
COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL
-
covid-19 (sars-cov-2) vaccine (recombinant adenovirus vector)
JCOVDEN
-
covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector)
VAXZEVRIA (NOTE 2)
-
creams
NULL
-
dabigatran etexilate methanesulfonate
PRADAXA
-
dabrafenib mesilate
TAFINLAR INITIAL APPROVAL
-
daclatasvir hydrochloride
DAKLINZA
-
daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride
XIMENCY
-
dacomitinib hydrate
VIZIMPRO
-
dapagliflozin propylene glycolate hydrate
FORXIGA INITIAL APPROVAL
-
darinaparsin
DARVIAS
-
diquafosol sodium
DIQUAS
-
dithranol
NULL
Frequently asked questions
What is the NovaPharmaNews drugs directory?
It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.
Where does drug approval data come from?
Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.
How do I find a drug by brand name?
Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.